Company / Interest Expense
PACIFIC BIOSCIENCES OF CALIFORNIA, INC. Interest Expense History
FY2016-FY2023 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Interest Expense
$14.3M
FY2023
5-year range
$12.5M / $14.7M
FY2019-FY2023
Trend
-2.4%
vs FY2022
Sector context
#35 of 43
Health Care
What the data says
PACIFIC BIOSCIENCES OF CALIFORNIA, INC.'s interest expense of $14M is lower than 81% of companies in the Health Care sector (FY2023). Interest Expense has fluctuated over the past 8 years, ranging from $267,000 in FY2020 to $15M in FY2022.
Based on SEC 10-K filings.
$14M in FY2023 with a 5-year CAGR of +42.7%.
Increased from $13M to $14M over the past 2 years.
Health Care sector context is included.
Interest Expense over time
Growth rates
- 3-Year CAGR
- +277.3%
- 5-Year CAGR
- +42.7%
- 10-Year CAGR
- -
Sector benchmark
Top 19% in Health CareTop 19% of 43This company $14.3M Sector average $324.8M
▼
-95.6% below sector average
Key checks
Key Insights
- 5-year CAGR of +42.7%, indicating consistent growth.
- In FY2023, interest expense decreased 2.4% year-over-year.
- Ranks #35 out of 43 companies in the Health Care sector.
- Peak interest expense was recorded in FY2022.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -1.92 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Interest ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | $14.3M | -2.4% |
| FY2022 | $14.7M | +17.2% |
| FY2021 | $12.5M | +4592.9% |
| FY2020 | $267.0K | -89.8% |
| FY2019 | $2.6M | +7.8% |
| FY2018 | $2.4M | -17.0% |
| FY2017 | $2.9M | -9.7% |
| FY2016 | $3.2M | +30.5% |
As of FY2023 · SEC 10-K · Updated Jun 30, 2026